The pharmaceutical industry is undergoing a significant transformation driven by numerous factors. These include the need for greater R&D efficiency, reducing expenditure for in-market assets to refresh the pipeline and adapting to a more diversified knowledge exchange ecosystem — all calling for greater efficiency. Within this transformation, the role of medical affairs teams and the challenges these teams face are changing. Medical affairs teams are increasingly challenged to do more with less, managing a growing number of assets with shrinking budgets and tighter timelines.
In this eBook you’ll learn about:
Jump to a slide with the slide dots.
Explore key trends & strategic insights from ASCO® 2025 in our eBook—AI, analytics, engagement, and beyond the booth.
Read moreExpert strategies to navigate pre-launch challenges and ensure a successful life sciences product launch. Download the guide.
Read moreDiscover how AI can significantly accelerate drug development by enhancing various aspects of clinical trial design in this article.
Read more